Is ESAB a Buy? What to Consider in 2026
Short answer
The bull case for ESAB Corporation (ESAB) rests on Recurring consumables base: A large share of ESAB's revenue comes from welding and cutting consumables that customers reorder continuously, a razor-and-blades dynamic that smooths results versus pure equipment makers. Revenue (TTM) is ~$2.85B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter. Whether ESAB is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
ESAB Corporation, founded in 1904 and spun out as a standalone public company in 2022, is one of the three largest welding and cutting businesses in the world alongside Lincoln Electric and Illinois Tool Works. It sells welding and cutting equipment, automation systems, and the electrodes, wires, and cutting consumables used across general industry, construction, infrastructure, transportation, energy, renewables, and medical gas control. The consumables side generates recurring, razor-and-blades style revenue, and roughly 80% of sales come from outside the United States, with about half of revenue from high-growth regions like South America, India, and Asia Pacific. The investment picture is that of an industrial compounder: steady organic growth layered with frequent bolt-on acquisitions (recent deals include EWM, Bavaria Schweisstechnik, and gas-control and medical-gas businesses), all integrated through the proprietary ESAB Business Excellence (EBX) system to expand margins. Revenue reached roughly $2.85 billion in 2025 and Q1 2026 set a record at about $746 million, though core-organic growth has been near flat and integration costs have pressured margins recently. The stock trades as a mid-cap industrial whose returns hinge on emerging-market end demand, currency, and management's ability to keep converting acquisitions into higher margins.
What's the case for buying ESAB?
1. Recurring consumables base
A large share of ESAB's revenue comes from welding and cutting consumables that customers reorder continuously, a razor-and-blades dynamic that smooths results versus pure equipment makers. This installed base of equipment pulls through repeat consumable sales for years. It gives the business a more stable revenue floor than the cyclical capital-equipment cycle alone would suggest.
2. Bolt-on M&A compounding
ESAB positions itself as an industrial compounder, pairing organic growth with a steady stream of tuck-in acquisitions in welding equipment, consumables, gas control, and medical gas. Deals such as EWM, Bavaria Schweisstechnik, and several gas-control businesses expand its portfolio and geographic reach. Management applies the EBX operating system to integrate these and lift acquired margins over time.
3. Emerging-market and high-growth exposure
About 80% of sales are outside the U.S., and roughly 52% of 2025 revenue came from high-growth regions including South America, India, and Asia Pacific. This tilt gives ESAB structural exposure to industrialization and infrastructure spending in faster-growing economies. It differentiates ESAB from more U.S.-centric welding peers.
4. EBX-driven margin expansion
The ESAB Business Excellence (EBX) system is management's lever for continuous cost and productivity improvement across manufacturing and integrated acquisitions. Core adjusted EBITDA margins have run near 19% to 20%. The stated strategy is to keep expanding margins even when organic sales growth is muted.
What are the risks to ESAB?
Roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter. Core-organic growth has been near flat recently while integration of acquisitions has pressured margins, so the compounder thesis depends on execution rather than end-market tailwinds. Geopolitical exposure is real: management flags the war in Ukraine and Middle East tensions, and Russian operations were around 5% of 2025 net sales. As an industrial supplier ESAB is cyclical, tied to construction, infrastructure, energy, and general fabrication activity. Legacy asbestos-related liabilities, supply-chain disruption, tariffs, and commodity input costs are additional overhangs disclosed in its filings.
How is ESAB valued? (as of JULY 2026)
Snapshot for ESAB as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$2.85B
- Q1 2026 sales: ~$746M (+10% reported)
- Core adj. EBITDA margin: ~19%
- 2026 sales guidance: ~$2.85B to $2.95B
- Market cap: ~$7.5B
- Q1 2026 core adj. EPS: ~$1.31
ESAB reported record Q1 2026 sales of about $746 million, up 10% on a reported basis but down roughly 1% on a core-organic basis, with core adjusted EPS of about $1.31. Management guided full-year 2026 sales to roughly $2.85 to $2.95 billion (about 6% to 9% total growth, 2% to 4% organic). With a market cap near $7.5 billion the stock carries a mid-to-high-20s earnings multiple typical of a quality industrial compounder.
How do you decide if ESAB is a buy?
Rather than asking whether ESAB is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold ESAB indirectly through an index or sector ETF before adding more.
For the full picture, see the ESAB stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about ESAB against your real portfolio and see your actual exposure before deciding.
The bottom line on ESAB
The bottom line: ESAB Corporation's story right now is Recurring consumables base, with revenue (ttm) at ~$2.85B. If you believe that narrative continues, the call is about sizing ESAB sensibly and checking overlap with what you own; if you doubt it (the risk: roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around ESAB with Walnut
Use ESAB Corporation as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is ESAB a good stock to buy right now?
+
The case for ESAB Corporation right now is Recurring consumables base, with revenue (ttm) at ~$2.85B. If you believe that thesis holds, ESAB is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does ESAB Corporation do?
+
ESAB Corporation, founded in 1904 and spun out as a standalone public company in 2022, is one of the three largest welding and cutting businesses in the world alongside Lincoln Ele
What are the main risks of ESAB?
+
Roughly 80% of sales come from outside the U.S., so currency swings and emerging-market demand volatility are the most pressing near-term risks and can overwhelm organic trends in any given quarter. Core-organic growth has been near flat recently while integration of acquisitions has pressured margins, so the compounder thesis depends on execution rather than end-market tailwinds. Geopolitical exposure is real: management flags the war in Ukraine and Middle East tensions, and Russian operations were around 5% of 2025 net sales. As an industrial supplier ESAB is cyclical, tied to construction, infrastructure, energy, and general fabrication activity. Legacy asbestos-related liabilities, supply-chain disruption, tariffs, and commodity input costs are additional overhangs disclosed in its filings.
What does ESAB Corporation do?
+
ESAB makes welding and cutting equipment, automation systems, and the consumables (electrodes, wires, cutting tips) used to run them. It also has a gas-control and medical-gas business. Customers span construction, infrastructure, energy, transportation, shipbuilding, and general fabrication.
Is ESAB a US-listed stock?
+
Yes. ESAB Corporation trades on the New York Stock Exchange under the ticker ESAB. It was spun off from Colfax (later Enovis) as a standalone public company in 2022. Note that Esab India is a separate listing on Indian exchanges.
How does ESAB make money?
+
ESAB sells welding and cutting equipment, then earns recurring revenue from the consumables customers reorder to keep using that equipment, a razor-and-blades model. Consumables provide a stable revenue base while equipment and automation drive newer growth.
Who are ESAB's main competitors?
+
Its closest peers are Lincoln Electric and Illinois Tool Works (owner of Miller Electric), the other two global welding leaders. Fronius, Kemppi, Panasonic Connect, and Air Liquide compete in specific equipment, automation, and gas-control niches.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell ESAB; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.